LONDON BROKER RATINGS: Citi cuts United Utilities and Severn Trent
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 1,901.00p on 01-05-2026 at 18:50:07 |
|---|---|
| Change | -27.50p -1.43% |
| Buy | 1,898.50p |
| Sell | 1,897.50p |
| Last Trade: | Unknown 3,108.00 at 1,901.00p |
| Day's Volume: | 4,930,028 |
| Last Close: | 1,901.00p |
| Open: | 1,928.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,892.50p - 1,928.50p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £75.89b |
| VWAP: | 1,913.47487p |
| Shares in Issue: | 3.99b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 3,108 | 1,901.00p | OTC Trade |
16:37:00 - 01-May-26 |
| Buy* | 834 | 1,901.00p | SI Trade |
16:35:29 - 01-May-26 |
| Buy* | 85 | 1,901.00p | SI Trade |
16:35:29 - 01-May-26 |
| Buy* | 4,837 | 1,901.00p | SI Trade |
16:35:29 - 01-May-26 |
| Buy* | 9,991 | 1,901.00p | SI Trade |
16:35:29 - 01-May-26 |
| Buy* | 18,192 | 1,901.00p | SI Trade |
16:35:29 - 01-May-26 |
| Buy* | 1,057,243 | 1,901.00p | Suspected BUY Trade |
16:35:29 - 01-May-26 |
| Buy* | 50 | 1,898.984p | Ordinary |
16:29:59 - 01-May-26 |
| Buy* | 2 | 1,898.00p | SI Trade |
16:29:59 - 01-May-26 |
| Buy* | 200 | 1,898.00p | Automatic Execution |
16:29:59 - 01-May-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st May 2026 3:00 pm | RNS | Holding(s) in Company |
| 1st May 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 29th Apr 2026 7:00 am | RNS | 1st Quarter Results |
| 28th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Apr 2026 7:00 am | RNS | Bepirovirsen priority review US filing acceptance |
| 27th Apr 2026 12:00 pm | RNS | Efimosfermin granted US/EU regulatory designations |
| 27th Apr 2026 7:00 am | RNS | TESARO update on AnaptysBio Inc. litigation |
| 24th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 23rd Apr 2026 7:00 am | RNS | Transaction in Own Shares |